Related Experiment Videos
Effect of phencyclidine on [3H]QNB binding
Life Sciences
|April 5, 1982
Summary
Phencyclidine (PCP) increased brain radioactivity from [3H] Quinuclidinyl benzilate (QNB) in mice, an effect blocked by atropine. This contrasts with in vitro findings on muscarinic receptor binding.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Phencyclidine (PCP) is a dissociative drug with complex neurochemical effects.
- Muscarinic cholinergic receptors play crucial roles in various brain functions.
- Previous in vitro studies indicated PCP inhibits [3H] Quinuclidinyl benzilate (QNB) binding to muscarinic receptors.
Purpose of the Study:
- To investigate the in vivo effects of phencyclidine (PCP) on the brain distribution of [3H] Quinuclidinyl benzilate (QNB).
- To examine the influence of atropine pretreatment on PCP-induced changes in [3H]-QNB brain uptake.
- To reconcile in vivo findings with existing in vitro data on PCP and muscarinic receptor interactions.
Main Methods:
- Female C57BL/6J mice received intraperitoneal injections of phencyclidine (PCP) followed by intravenous [3H]-QNB.
- Brain regions including the hypothalamus, cortex, hippocampus, and striatum were analyzed for radioactivity one hour post-injection.
- Atropine pretreatment was used to assess its modulatory effect on [3H]-QNB uptake.
- In vitro binding assays were conducted using tissue samples from animals treated with PCP or atropine in vivo.
Main Results:
- Intraperitoneal PCP administration significantly increased [3H]-QNB brain radioactivity in multiple regions (hypothalamus, cortex, hippocampus, striatum).
- This enhancement effect was dose-dependent but consistent over the time span studied.
- Atropine pretreatment effectively blocked the PCP-induced increase in brain [3H]-QNB levels.
- No significant effects on [3H]-QNB binding were observed when tissue was analyzed in vitro after in vivo drug administration.
Conclusions:
- In vivo, PCP enhances the brain uptake of [3H]-QNB, suggesting complex interactions beyond direct receptor blockade.
- Atropine antagonizes the in vivo effects of PCP on [3H]-QNB distribution.
- Discrepancies between in vivo and in vitro results highlight the need for further investigation into the mechanisms underlying PCP's neurochemical actions.